RecruitingNCT05515341

A DirEct to PatieNt Study in Chronic Pain

Sponsor

Boston Scientific Corporation

Enrollment

50,000 participants

Start Date

Jan 10, 2023

Study Type

OBSERVATIONAL

Conditions

Chronic Pain

Summary

To compile real-world, direct from patient clinical outcomes and objective metrics in patients who have received or plan to receive a commercially approved interventional medical device therapy/procedure for chronic pain in routine clinical practice.

Eligibility

Min Age: 22 Years

Inclusion Criteria3

Patient is planning to receive or has received a commercially approved interventional medical device therapy/procedure to treat chronic pain, ascertained from self-reporting
Age ≥ 22 years at time of eligibility screening, ascertained by self-reported age at time of eligibility screening
Proficient in written and spoken English, defined by self-reporting of comfort reading, writing and speaking English